FDG-PET in the initial staging of squamous cell oesophageal carcinoma

NuklearMedizin

Volumn 45, Issue 6, 2006, Pages 235-241

  Buchmann, Inga ^a,c   Hansen, T ^a,b   Brochhausen, C ^a   Kneist, W ^a   Oberholzer, K ^a   Junginger, T ^a   Schreckenberger, M ^a   Bartenstein, P ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

FDG PET; Metastases; Oesophageal cancer; Squamous cell carcinoma; Tumour staging

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG UPTAKE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LYMPH NODE METASTASIS; MALE; POSITRON EMISSION TOMOGRAPHY; RADIODIAGNOSIS;

EID: 33845947931     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1625108     Document Type: Article

References (28)

1. rd ed. Philadelphia: JB Lippincott 1998; 63-7.
2. Block MI, Pattersen GA, Sundaresan RS et al. Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg 1997; 64: 770-6.
3. Bonavina L, Incarbone R, Lattuada E et al. Preoperative laparoscopy in management of patients with carcinoma of the esophagus and of the esophagogastric junction. J Surg Oncol 1997; 65: 171-4.
4. 18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: Prognostic implications. J Nucl Med 2004; 45: 1843-50.
5. Choi JY, Lee KH, Shim YM et al. Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG-PET. J Nucl Med 2000; 41: 808-15.
6. Dietl B, Marienhagen J. The therapeutic impact of (18)F-FDG whole body PET. A radiooncologist's view. Nuklearmedizin 2005; 44: 8-14.
7. Flamen P, Lerut A, Van Cutsem E et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J of Clin Oncol 2000; 18: 3202.
8. 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol 1997; 168: 417-24.
9. Fujita H, Sueyoshi S, Tanaka T et al. Prospective non-randomized trial comparing esophagectomy-followed-by-chemotherapy versus chemotherapy-followed- by-esophagectomy for T4 esophageal cancers. J Surg Oncol 2005; 90: 209-19.
10. Herrmann T. Radiation oncology and functional imaging. Nuklearmedizin 2005; 44 (Suppl 1): S38-40.
11. Ishikawa H, Sakurai H, Yamakawa M et al. Clinical outcomes and prognostic factors for patients with early esophageal squamous cell carcinoma treated with definitive radiation therapy alone. J Clin Gastroenterol 2005; 39: 495-500.
12. 18F- fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma. Anticancer Res 2003; 23: 3263-72.
13. Keyes JW Jr. SUV: standard uptake or silly useless value? J Nucl Med 1995; 36: 1836-9.
14. Kneist W, Schreckenberger M, Bartenstein P et al. Prospective evaluation of positron emission tomography in the preoperative staging of esophageal carcinoma. Arch Surg 2004; 139: 1043-9.
15. Lerut T, Flamen P, Ectors N et al. Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: A prospective study based on primary surgery with extensive lymphadenectomy. Ann Surg 2000; 232: 743-52.
16. Liao Z, Zhang Z, Jin J et al. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Int J Radiat Oncol Biol Phys 2004; 60: 1484-93.
17. Liberale G, van Laethem JL, Gay F et al. The role of PET scan in the preoperative management of oesophageal cancer. Eur J Surg Oncol 2004; 30: 942-7.
18. Luketich JD, Schauer P, Landreneau R et al. Minimally invasive surgical staging is superior to endoscopic ultrasound in detecting lymph node metastases in esophageal cancer. J Thor and Cardiovasc Surg 1997; 114: 817-23.
19. Luketich, Friedman DM, Weigel TL et al. Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans. Ann Thorac Surg 1999; 68: 1133-6.
20. Räsanen JV, Sihvon EIT, Knuuti MJ et al. Prospective analysis of accuracy and positron emission tomography, computed tomography, and endoscopic ultrasonographic in staging of adenocarcinoma of the esophagus and the esophagogastric junction. Ann Surg Oncol 2003; 10: 954-60.
21. th ed. New York: Wiley-Liss 1997.
22. Stahl A, Stollfuss J, Ott K et al. FDG PET and CT in locally advanced adenocarcinomas of the distal esophagus. Clinical relevance of a discordant PET finding. Nuklearmedizin 2005; 44: 249-55.
23. Stewart BW, Kleihues P (eds). World cancer report. In: International Agency for Research on Cancer. Lyon: 2003.
24. Strauss LG. Fluorine-18 deoxyglucose and false-positive results: A major problem in the diagnosis of oncological patients. Eur J Nucl Med 1996; 23: 1409-15.
25. Sugarbaker DJ, Jaklitsch MT, Liptay MJ. Thoracoscopic staging and surgical therapy for esophageal cancer. Chest 1995; 107 (suppl 6): 218S-23S.
26. Tio TL, Coene PP, den Hartog Jager FC et al. Preoperative TNM classification of esophageal carcinoma by endosonography. Hepato- gastroenterology 1990; 37: 376-81.
27. Wren SM, Stijns P, Srinivas S. Positron emission tomography in the initial staging of esophageal cancer. Arch Surg 2002; 137: 1001-7.
28. Ziegler K, Sanft C, Zeitz M et al. Evaluation of endosonography in TN staging of oesophageal cancer. Gut 1991; 32: 16-20.